Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Feb 22;20(6):794–800. doi: 10.1016/j.bbmt.2014.02.012

TABLE 2.

Distribution of pre- and post-transplant cardiovascular risk factors among sub-cohort (n=509*).

Trait, n (%) Pre-transplant 1-yr post-transplant Last follow-up
History of tobacco use 171 (33.8) - -
  Current user 49 (9.7) - -

Body mass index, kg/m2
  Underweight, <18.5 11 (2.2) 21 (4.3) -
  Normal, 18.5–24 206 (41.4) 224 (46.2) -
  Overweight, 25–29 167 (33.5) 138 (28.5) -
  Obese, ≥30 114 (22.9) 102 (21.0) -

Hypertension treatment 34 (6.7) 98 (19.6) 119 (23.9)
  On treatment at prior time point, still on - 28 (5.6) 63 (12.7)
  Off treatment at prior time point, now on - 70 (14.0) 56 (11.2)
  On treatment at prior time point, now off - 6 (1.2) 34 (6.8)

Dyslipidemia treatment 15 (3.0) 14 (2.8) 79 (15.8)
  On treatment at prior time point, still on - 7 (1.4) 13 (2.6)
  Off treatment at prior time point, now on - 7 (1.4) 64 (12.8)
  On treatment at prior time point, now off - 8 (1.6) 1 (0.2)

Diabetes treatment 21 (4.1) 65 (12.9) 54 (10.7)
  On treatment at prior time point, still on - 21 (4.2) 31 (6.2)
  Off treatment at prior time point, now on - 44 (8.7) 23 (4.6)
  On treatment at prior time point, now off - 0 34 (6.7)
*

Percentages based on those with data among the sub-cohort (depending on the risk factor and time point, n=498 to 509).

Only assessed pre-transplant.

Limited to those age ≥2 years. Values for survivors ages 2–20 years based on equivalent age- and sex-specific percentiles. Only assessed pre-transplant and 1-yr post-transplant.

HHS Vulnerability Disclosure